CY1564A - Bromocriptine compositions - Google Patents

Bromocriptine compositions

Info

Publication number
CY1564A
CY1564A CY1564A CY156491A CY1564A CY 1564 A CY1564 A CY 1564A CY 1564 A CY1564 A CY 1564A CY 156491 A CY156491 A CY 156491A CY 1564 A CY1564 A CY 1564A
Authority
CY
Cyprus
Prior art keywords
bromocriptine
compositions
bromocriptine compositions
Prior art date
Application number
CY1564A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848405227A external-priority patent/GB8405227D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY1564A publication Critical patent/CY1564A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY1564A 1984-02-29 1991-05-17 Bromocriptine compositions CY1564A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB08504788A GB2154874B (en) 1984-02-29 1985-02-25 Bromoscriptine compositions

Publications (1)

Publication Number Publication Date
CY1564A true CY1564A (en) 1991-05-17

Family

ID=26287383

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1564A CY1564A (en) 1984-02-29 1991-05-17 Bromocriptine compositions

Country Status (3)

Country Link
CY (1) CY1564A (en)
GB (1) GB2154874B (en)
MY (1) MY101029A (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
NL194822C (en) * 1985-10-01 2003-04-03 Novartis Ag Preparation for oral administration with controlled release and method for its preparation.
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN
SE8703881D0 (en) * 1987-10-08 1987-10-08 Haessle Ab NEW PHARMACEUTICAL PREPARATION
IT1235053B (en) * 1989-04-07 1992-06-17 Poli Ind Chimica Spa METHODS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON BROMOCRIPTINE EQUIPPED WITH HIGH STABILITY AND DERIVING PRODUCTS.
FR2656525A1 (en) * 1989-12-29 1991-07-05 Delalande Sa Controlled-release pharmaceutical dosage forms and process for manufacturing them
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
CN104013971B (en) * 2014-06-23 2017-09-26 深圳翰宇药业股份有限公司 A kind of bromocriptine composition sustained-release preparation and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
GB2154874A (en) 1985-09-18
GB8504788D0 (en) 1985-03-27
MY101029A (en) 1991-06-29
GB2154874B (en) 1987-11-04

Similar Documents

Publication Publication Date Title
SG18692G (en) Liposome-gel compositions
GB8518876D0 (en) Composition
GB8526284D0 (en) Composition
GB8527242D0 (en) Dental-caries-preventative composition
GB8500581D0 (en) Orgaopolysiloxane composition
AR241929A1 (en) Detergent composition
HK7991A (en) Compositions
PT80275A (en) Compositions
GB8521762D0 (en) Detergent-softener compositions
GB8507516D0 (en) Compositions
GB8416923D0 (en) Composition
GB8517349D0 (en) Composition
CY1564A (en) Bromocriptine compositions
GB8521761D0 (en) Detergent-softener compositions
GB8418082D0 (en) Compositions
GB8502426D0 (en) Composition
GB8524867D0 (en) Ceramics-forming composition
ZA851546B (en) Bromocriptine compositions
GB8508284D0 (en) Compositions
GB2158714B (en) Composition
DE3571121D1 (en) Novel compositions
GB8521760D0 (en) Detergent-softener compositions
ZA85703B (en) Compositions
GB8414024D0 (en) Zeolite-derived compositions
ZM2785A1 (en) Compositions